Temple Health physicians and scientists are finding innovative solutions to treat complex conditions, create better options and develop next-generation treatments. Find out how Temple Health is helping more patients live better lives.
Dissatisfied with current treatments for DVT and PE, Dr. Riyaz Bashir designed a new solution that uses a specialized catheter and the body’s own blood to dissolve clots much more quickly and with less medication than current methods.
Over the past 6 years, the Temple Lung Center has performed more lung transplants than any other hospital in the country. We're also one of the first to transplant a patient with post-COVID lung failure.
The Temple MDA/ALS Center of Hope is a national leader in helping people with ALS and other neuromuscular diseases manage their condition, offering specialized care and clinical trials not found at most hospitals.
A recognized leader in the development of new pulmonary therapies, Temple physicians have led the development of a breakthrough treatment option for patients with severe emphysema.
While managing some of the highest COVID-19 volumes in Philadelphia, Temple’s medical team has simultaneously achieved survival rates far better than the national and regional averages.
Attracting patients from across the country, Temple is delivering the cure for a rare form of pulmonary hypertension called CTEPH.
Through extensive collaboration with research colleagues throughout the country, Temple is a national leader in helping patients with lung disease live their healthiest lives.
Temple robotic surgeons are making it possible for more patients to receive livesaving therapies after being told they were out of options.
Adult patients who are suffering from tracheobronchomalacia (TBM) — a collapse of the windpipe and bronchial tubes — can find expertise at Temple, a destination center for this rare condition.
Temple cardiovascular researchers are developing new therapies that may one day dramatically change how patients are treated after a heart attack or heart failure.
Temple researchers are leveraging CRISPR technology that may be an effective pathway to ridding people infected with HIV of the virus without harming them.
Over 200 hospitals throughout the region depend on Temple to care for their most critically injured and sick patients.
For over 20 years, Temple has been the regional leader in providing burn care for the most serious burns.